DE60135845D1 - Pralmorelin-haltige nasentropfen-präparate - Google Patents

Pralmorelin-haltige nasentropfen-präparate

Info

Publication number
DE60135845D1
DE60135845D1 DE60135845T DE60135845T DE60135845D1 DE 60135845 D1 DE60135845 D1 DE 60135845D1 DE 60135845 T DE60135845 T DE 60135845T DE 60135845 T DE60135845 T DE 60135845T DE 60135845 D1 DE60135845 D1 DE 60135845D1
Authority
DE
Germany
Prior art keywords
pralmorelin
alanyl
preparation
nose drop
drop preparations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60135845T
Other languages
English (en)
Inventor
Akiko Ochiai
Yasutomi Kato
Hirokuni Kogetsu
Kiyoshi Maruyama
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
Original Assignee
Kaken Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd filed Critical Kaken Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60135845D1 publication Critical patent/DE60135845D1/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DE60135845T 2000-05-29 2001-05-29 Pralmorelin-haltige nasentropfen-präparate Expired - Fee Related DE60135845D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000158676A JP3498041B2 (ja) 2000-05-29 2000-05-29 プラルモレリン含有点鼻用製剤
PCT/JP2001/004503 WO2001091782A1 (fr) 2000-05-29 2001-05-29 Preparations de gouttes nasales contenant de la pralmoreline

Publications (1)

Publication Number Publication Date
DE60135845D1 true DE60135845D1 (de) 2008-10-30

Family

ID=18663108

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60135845T Expired - Fee Related DE60135845D1 (de) 2000-05-29 2001-05-29 Pralmorelin-haltige nasentropfen-präparate

Country Status (7)

Country Link
US (1) US7008927B2 (de)
EP (1) EP1297838B1 (de)
JP (1) JP3498041B2 (de)
AT (1) ATE408413T1 (de)
AU (1) AU2001258859A1 (de)
DE (1) DE60135845D1 (de)
WO (1) WO2001091782A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101193626A (zh) * 2005-03-11 2008-06-04 益德威士医药股份有限公司 奥曲肽的受控释放制剂
US7759312B2 (en) * 2005-03-11 2010-07-20 Endo Pharmaceuticals Solutions Inc. Delivery of dry formulations of octreotide
CN101583274A (zh) * 2006-12-29 2009-11-18 雷文斯治疗公司 使用反向序列hiv-tat多肽的运输分子
EP2303226B1 (de) * 2008-06-25 2016-03-23 Endo Pharmaceuticals Solutions Inc. Verlängerte freisetzung von exenatid und anderen polypeptiden
WO2009158415A1 (en) * 2008-06-25 2009-12-30 Endo Pharmaceuticals Solutions Inc. Octreotide implant having a release agent

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0080879B1 (de) 1981-11-28 1986-10-01 Sunstar Kabushiki Kaisha Stabilisiertes Interferon enthaltende pharmazeutische Zusammensetzung
JPS63303931A (ja) 1987-06-05 1988-12-12 Sumitomo Pharmaceut Co Ltd 経鼻投与用成長ホルモン放出活性物質製剤
IT1222395B (it) * 1987-07-30 1990-09-05 Pierrel Spa Composizione farmaceutica per somministrazione intranasale comprendente l'ormone ghrh,un agonista colinergico e/o un sale biliare
JP3179538B2 (ja) 1990-12-11 2001-06-25 ノバルティス アクチエンゲゼルシャフト 安定なヒトカルシトニンの水性溶液
US5663146A (en) * 1991-08-22 1997-09-02 Administrators Of The Tulane Educational Fund Polypeptide analogues having growth hormone releasing activity
CA2174324A1 (en) 1993-10-21 1995-04-27 Katsuya Mukae Pernasal composition and pernasal preparation containing the same
JP2660484B2 (ja) 1994-04-12 1997-10-08 株式会社ミドリ十字 ヒト尿性トリプシンインヒビター含有液状製剤
JPH1045619A (ja) 1996-07-31 1998-02-17 Kaken Pharmaceut Co Ltd 成長ホルモン分泌促進ペプチド含有経口製剤
US5932548A (en) 1998-06-03 1999-08-03 Deghenghi; Romano Lysine containing peptides for treatment of heart disease
US6878689B2 (en) * 2000-06-23 2005-04-12 Kaken Pharmaceutical Co., Ltd. Preventives or remedies for heart failure
JP2002053489A (ja) * 2000-08-07 2002-02-19 Kaken Pharmaceut Co Ltd 筋肉増強剤・筋肉減衰の予防・治療剤

Also Published As

Publication number Publication date
US20030139347A1 (en) 2003-07-24
US7008927B2 (en) 2006-03-07
ATE408413T1 (de) 2008-10-15
EP1297838A1 (de) 2003-04-02
EP1297838B1 (de) 2008-09-17
WO2001091782A1 (fr) 2001-12-06
AU2001258859A1 (en) 2001-12-11
JP2001335508A (ja) 2001-12-04
JP3498041B2 (ja) 2004-02-16
EP1297838A4 (de) 2003-07-09

Similar Documents

Publication Publication Date Title
CO5271759A1 (es) Formulacion en solucion que contiene una mezcla de disolventes
DK1091729T3 (da) Mikropartikelformulering til inhalation
DK1317419T3 (da) Cyanophenoxycarboxylsyre-forbindelser og sammensætninger til at levere aktive midler
ITMI912024A1 (it) Composizioni terapeutiche per somministrazione intranasale comprendenti ketorolac.
CA2301017A1 (en) Use of propyl gallate to increase bioavailability of orally administered pharmaceutical compounds
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
HRP20020404B1 (en) Solutions containing epinastine
PL357132A1 (en) Stable, nasally, orally or sublingually applicable pharmaceutical preparation
ATE455539T1 (de) Darreichungsformen mit verlängerter wirkstofffreisetzung
DK1228758T3 (da) Anvendelse af sulfodehydroabietinsyre til behandling af inflammatorisk tarmsygdom
SE0002476D0 (sv) New compounds
DE60135845D1 (de) Pralmorelin-haltige nasentropfen-präparate
NO912414L (no) Forbindelse med mavesyreinhiberende effekt og fremgangsmaate for dens fremstilling.
WO2001051028A3 (en) Formulations and methods for administration of pharmacologically or biologically active compounds
EP0647616A4 (de) Zink-tranexamat derivat.
ATE291421T1 (de) Pharmazeutische, ramipril enthaltende brauseformulierung
CA2406179A1 (en) Use of defibrotide and at least one haematopoietic factor to mobilize haematopoietic progenitors
DK1220678T3 (da) Farmaceutiske præparater indeholdende kobber, salicylsyre og C-vitamin
SE9900177L (sv) Användning av en beredning innehållande myrsyra för framställning av ett läkemedel för behandling av vårtor, orsakade av Papillomavirus
UY26459A1 (es) 3,4-dihidroquinazolinas 5,6-disustituidas
GT199900171A (es) Concentrado oral de sertralina.
TR200302027T4 (tr) Hayvanlarda görülen parazit kaynaklı hastalıkarın tedavisine yönelik ilaç kompozisyonları
TR200102087T2 (tr) Yeni morfolinbenzamid tuzları
WO2001045727A3 (en) Stabilized veterinary compositions comprising more than one antiviral agent
JPS643123A (en) Remedy for skin inflammation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee